New TAVI Tussle But It’s Edwards In The Dock
This article was originally published in Clinica
Just over a year after settling a long legal wrangle with Medtronic over patents related to transcatheter aortic valve implantation technology, Edwards Lifesciences is once again becoming embroiled in another TAVI suit – this time, however, it is the one accused of infringement.
You may also be interested in...
As its dispute with Boston Scientific over transcatheter aortic valve replacement technology patents rumbles on, Edwards Lifesciences is offering German interventionalists the option to buy six-months' worth of its Sapien 3 inventory in anticipation of a potential disruption to the supply flow.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.